Select Ongoing Trials Currently Enrolling Patients with Head and Neck Cancer.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 8, p. 25
- Publication type:
- Article
Works matching IS 21644403 AND DT 2022 AND VI 12 AND IP 8
Results: 9
1
2
Digital Therapeutics Is the Key to New Patient Management Demands for Physicians.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 8, p. 21
- By:
- Publication type:
- Article
3
The Drug Pricing 'Slippery Slope': Rep. Peter Welch breaks the code on the Senate's new price controls.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 8, p. 20
- Publication type:
- Article
4
FAQs on Medicare Coverage of Telehealth.
- Published in:
- 2022
- By:
- Publication type:
- Question & Answer
5
Black Patients with Cancer and COVID-19 More Likely to Have Treatment Disruptions Than White Patients.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 8, p. 9
- By:
- Publication type:
- Article
6
Lisocabtagene Maraleucel Yields High Response Rates in Patients with Relapsed or Refractory LBCL Who Are Not Candidates for Transplant.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 8, p. 7
- By:
- Publication type:
- Article
7
The Patient Experience: How to Plan for Success.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 8, p. 1
- By:
- Publication type:
- Article
8
Getting Real with the New Enhancing Oncology Model.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 8, p. 1
- By:
- Publication type:
- Article
9
Trastuzumab Deruxtecan a New Standard for Patients with HER2-Low Metastatic Breast Cancer.
- Published in:
- Oncology Practice Management, 2022, v. 12, n. 8, p. 1
- By:
- Publication type:
- Article